Cell-based Models To Investigate Tau Aggregation
- PMID: 25505502
- PMCID: PMC4262059
- DOI: 10.1016/j.csbj.2014.09.011
Cell-based Models To Investigate Tau Aggregation
Abstract
Accumulation of abnormal tau aggregates in neuron is an important pathological signature in multiple neurodegenerative disorders including Alzheimer's disease. Tau is a neuron specific microtubule-associated protein that regulates microtubule stability, which is critical for axonal outgrowth and synaptic plasticity. In a pathological condition, tau dissociates from microtubules and forms insoluble aggregates called neurofibrillary tangles (NFTs). The accumulation of NFTs in neuron directly correlates with microtubule dysfunction and neuronal degeneration. Due to the pathophysiological importance of tau, great efforts have been made to understand tau aggregation processes and find therapeutics to halt or reverse the processes. However, progress has been slow due to the lack of a suitable method for monitoring tau aggregation. In this mini-review, we will review the conventional methods for studying tau aggregation, and introduce recent cell-based sensor approaches that allow monitoring tau aggregation in living cells.
Keywords: BiFC; Cell-based sensor; In vitro assay; Tau oligomerization; Tau phosphorylation; Tauopathy.
Figures





Similar articles
-
Visualization of Tau⁻Tubulin Interaction in a Living Cell Using Bifluorescence Complementation Technique.Int J Mol Sci. 2018 Sep 29;19(10):2978. doi: 10.3390/ijms19102978. Int J Mol Sci. 2018. PMID: 30274285 Free PMC article.
-
Tumor-suppressor PTEN affects tau phosphorylation, aggregation, and binding to microtubules.FASEB J. 2006 Jun;20(8):1272-4. doi: 10.1096/fj.06-5721fje. Epub 2006 Apr 27. FASEB J. 2006. PMID: 16645045
-
Tau Pathology in Parkinson's Disease.Front Neurol. 2018 Oct 2;9:809. doi: 10.3389/fneur.2018.00809. eCollection 2018. Front Neurol. 2018. PMID: 30333786 Free PMC article. Review.
-
Targeting post-translational modifications on tau as a therapeutic strategy for Alzheimer's disease.J Neurogenet. 2011 Dec;25(4):127-33. doi: 10.3109/01677063.2011.626471. J Neurogenet. 2011. PMID: 22091726 Review.
-
Tau Oligomers Neurotoxicity.Life (Basel). 2021 Jan 6;11(1):28. doi: 10.3390/life11010028. Life (Basel). 2021. PMID: 33418848 Free PMC article. Review.
Cited by
-
Tau aggregation induces cell death in iPSC-derived neurons.Aging Brain. 2025 Apr 11;7:100136. doi: 10.1016/j.nbas.2025.100136. eCollection 2025. Aging Brain. 2025. PMID: 40276591 Free PMC article.
-
Red Ginseng Inhibits Tau Aggregation and Promotes Tau Dissociation In Vitro.Oxid Med Cell Longev. 2020 Jun 30;2020:7829842. doi: 10.1155/2020/7829842. eCollection 2020. Oxid Med Cell Longev. 2020. PMID: 32685100 Free PMC article.
-
The duality of amyloid-β: its role in normal and Alzheimer's disease states.Mol Brain. 2024 Jul 17;17(1):44. doi: 10.1186/s13041-024-01118-1. Mol Brain. 2024. PMID: 39020435 Free PMC article. Review.
-
Human cells adapt to translational errors by modulating protein synthesis rate and protein turnover.RNA Biol. 2020 Jan;17(1):135-149. doi: 10.1080/15476286.2019.1670039. Epub 2019 Oct 1. RNA Biol. 2020. PMID: 31570039 Free PMC article.
-
Aggregation, Transmission, and Toxicity of the Microtubule-Associated Protein Tau: A Complex Comprehension.Int J Mol Sci. 2023 Oct 9;24(19):15023. doi: 10.3390/ijms241915023. Int J Mol Sci. 2023. PMID: 37834471 Free PMC article. Review.
References
-
- Binder L.I., Guillozet-Bongaarts A.L., Garcia-Sierra F., Berry R.W. Tau, tangles, and Alzheimer's disease. Biochim Biophys Acta. 2005;1739:216–223. - PubMed
-
- Johnson G.V., Hartigan J.A. Tau protein in normal and Alzheimer's disease brain: an update. J Alzheimers Dis. 1999;1:329–351. - PubMed
-
- Brandt R., Hundelt M., Shahani N. Tau alteration and neuronal degeneration in tauopathies: mechanisms and models. Biochim Biophys Acta. 2005;1739:331–354. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources